Search Congress
Bills
40 shown of 106 matchesRestore Prescription Drugs Discount Act
Restore prescription drug discount protections by reinstating a specific prescription drugs discount policy under federal law
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
Referred to the House Committee on Energy and Commerce.
Safe and Affordable Drugs from Canada Act of 2025
Require the FDA to permit personal importation of certain prescription drugs from approved Canadian pharmacies under specified safety and quantity limits
VA National Formulary Act of 2025
Establishes a national formulary framework for Department of Veterans Affairs prescription drugs in 2025
Health Care PRICE Transparency Act
Require hospitals and health insurance plans to publicly disclose detailed prices for items, services, and prescription drugs so consumers can compare health care costs
Rx ACCESS Act
Expand prescription drug access by revising rules and requirements under the Rx ACCESS Act
Prescription Freedom Act of 2025
Eliminates FDA authority to require prescription-only dispensing for most drugs while keeping that authority for drugs intended to terminate a pregnancy
Capping Prescription Costs Act of 2025
Cap prescription drug costs in 2025 through federal legislation aimed at limiting what patients pay for medicines
Prescription Information Modernization Act of 2025
Modernizes prescription information requirements for prescription drugs under the Prescription Information Modernization Act of 2025
DTC Act of 2025
Requires certain prescription drug and biologic ads covered by Medicare or Medicaid to clearly disclose 30 day wholesale prices for consumers
Rx ACCESS Act
Expand access to prescription medications through the Rx ACCESS Act for affected patients or beneficiaries
Capping Prescription Costs Act of 2025
Cap out-of-pocket prescription drug costs by setting annual limits for covered patients
PBM Kickback Prohibition Act
Prohibits pharmacy benefit manager kickbacks, targeting rebate and compensation practices in prescription drug pricing
Protecting Patients from Deceptive Drug Ads Act
Establishes civil penalties, disclosure rules, and reporting requirements for deceptive prescription drug promotion on social media and through telehealth
Expanding Access to Affordable Drugs and Medical Devices Act
Expand access to lower-cost prescription drugs and medical devices by making them more affordable
Innovation in Pediatric Drugs Act of 2025
Expands FDA authority over pediatric studies for orphan drugs used in rare pediatric diseases and strengthens related research, enforcement, and reporting requirements
NOPAIN for Veterans Act
Establishes the NOPAIN for Veterans Act as legislation aimed at veterans' pain treatment policy
Saving Seniors Money on Prescriptions Act
Establishes Medicare pharmacy benefit manager reporting and disclosure requirements to increase prescription drug price transparency for seniors
Pharmacy Benefit Manager Transparency Act of 2025
Establishes new transparency requirements for pharmacy benefit managers to disclose pricing and business practices in the prescription drug market
Prescription Pricing for the People Act of 2025
Require the FTC to report on anticompetitive practices in the pharmaceutical supply chain that may affect prescription drug costs, including PBM conduct and sole source drug complaints
Equitable Community Access to Pharmacist Services Act
Expand Medicare payment for pharmacist services in underserved communities through community pharmacy settings
Ending Chemical Abortions Act of 2025
Prohibit the mailing or interstate distribution of chemical abortion drugs as proposed in the Ending Chemical Abortions Act of 2025
CLEAR LABELS Act
Establishes clearer consumer product labeling standards under the CLEAR LABELS Act
Biosimilar Red Tape Elimination Act
Eliminate regulatory requirements identified as red tape for biosimilar products
Access to Birth Control Act
Expand access to birth control by creating a federal measure on contraceptive availability
PLASMA Act
Phases in Medicare Part D manufacturer discount requirements for plasma-derived products over several years
Hidden Fee Disclosure Act of 2025
Require disclosure of hidden fees in education and workforce-related charges under the Hidden Fee Disclosure Act of 2025
Safe Step Act
Establishes requirements for step therapy protocols used in health insurance coverage to protect patient access to prescribed treatments
GUARD Veterans’ Health Care Act
Improve safeguards in veterans' health care through the GUARD Veterans’ Health Care Act
Safe Step Act
Establishes federal requirements for step therapy practices under health plans to create safer exceptions and review standards
Alternatives to PAIN Act
Reduces Medicare Part D cost sharing and utilization controls for certain non-opioid pain management drugs
Access to Birth Control Act
Establishes federal protections for obtaining and using birth control and limits barriers to contraceptive access
Second Chance for Moms Act
Requires mifepristone labeling to include specified information about progesterone and creates a related telephone hotline
GUARD Veterans’ Health Care Act
Establishes protections and oversight aimed at guarding veterans' access to health care services
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
Recognizes the history of diethylstilbestrol and the harm the drug has caused to affected people
ORPHAN Cures Act
Modifies Medicare drug price negotiation rules for orphan drugs by changing market approval timing and broadening exclusions for rare disease treatments
Rural 340B Access Act of 2025
Extends eligibility for the 340B drug pricing program to qualifying rural emergency hospitals so they can buy discounted outpatient drugs
Pregnancy Is Not an Illness Act of 2025
Prohibit the FDA from treating pregnancy as an illness when approving or regulating abortion drugs, and void affected approvals including mifepristone
U.S. Vets of the FAS Act
Establishes U.S. Vets of the Foreign Agricultural Service as the bill's recognized subject and purpose
Healthy Technology Act of 2025
Allows certain approved artificial intelligence or machine learning systems to qualify as prescribing practitioners for drugs when state law authorizes their use